Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients

被引：0
|
作者：
Pasternak, Amy [1 ]
Hong, Je-Won [1 ]
Lewis, Sarah [1 ]
机构：
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI USA
来源：
PHARMACOGENETICS AND GENOMICS | 2025年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [31] The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
    Agnieszka A. Prytuła
    Karlien Cransberg
    Antonia H. M. Bouts
    Ron H. N. van Schaik
    Huib de Jong
    Saskia N. de Wildt
    Ron A. A. Mathôt
    Clinical Pharmacokinetics, 2016, 55 : 1129 - 1143
  • [32] CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
    Chen, Lucy
    Prasad, G. V. Ramesh
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 : 23 - 33
  • [33] Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients
    Kotha, Chandini
    Sahay, Manisha
    TRANSPLANTATION, 2022, 106 (09) : S135 - S135
  • [34] The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
    van Gelder, Teun
    Meziyerh, Soufian
    Swen, Jesse J.
    de Vries, Aiko P. J.
    Moes, Dirk Jan A. R.
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [35] Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
    Uno, Takaya
    Wada, Kyoichi
    Matsuda, Sachi
    Terada, Yuka
    Oita, Akira
    Kawase, Atsushi
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2018, 43 (06) : 665 - 673
  • [36] Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
    Takaya Uno
    Kyoichi Wada
    Sachi Matsuda
    Yuka Terada
    Akira Oita
    Atsushi Kawase
    Mitsutaka Takada
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 665 - 673
  • [37] Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients
    Leino, Abbie D.
    Park, Jeong M.
    Pasternak, Amy L.
    PHARMACOTHERAPY, 2021, 41 (08): : 649 - 657
  • [38] Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
    Han, Nayoung
    Yun, Hwi-yeol
    Hong, Jin-yi
    Kim, In-Wha
    Ji, Eunhee
    Hong, Su Hyun
    Kim, Yon Su
    Ha, Jongwon
    Shin, Wan Gyoon
    Oh, Jung Mi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (01) : 53 - 63
  • [39] Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
    Nayoung Han
    Hwi-yeol Yun
    Jin-yi Hong
    In-Wha Kim
    Eunhee Ji
    Su Hyun Hong
    Yon Su Kim
    Jongwon Ha
    Wan Gyoon Shin
    Jung Mi Oh
    European Journal of Clinical Pharmacology, 2013, 69 : 53 - 63
  • [40] Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
    Zong, Huiying
    Zhang, Yundi
    Liu, Fengxi
    Zhang, Xiaoming
    Yang, Yilei
    Cao, Xiaohong
    Li, Yue
    Li, Anan
    Zhou, Penglin
    Gao, Rui
    Li, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345